|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$34.65 |
$35.34 |
$34.24 |
$34.84 |
325.40K | 04/22/2024 |
$34.93 |
$35.31 |
$34.55 |
$34.74 |
414.70K | 04/23/2024 |
$35.00 |
$36.51 |
$34.92 |
$35.94 |
618.70K | 04/24/2024 |
$35.83 |
$36.02 |
$35.33 |
$35.48 |
302.80K | 04/25/2024 |
$35.37 |
$36.01 |
$35.05 |
$35.84 |
338.00K |
|
Collegium Pharmaceutical is a pharmaceutical company. Co.'s portfolio includes: Xtampza ER, Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol. Xtampza ER was approved by the U.S. Food and Drug Administration for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic. | |
|
Collegium Pharmaceutical (COLL) has the following price history information. Looking back at COLL historical stock prices for the last five trading days, on April 19, 2024, COLL opened at $34.65, traded as high as $35.34 and as low as $34.24, and closed at $34.84. Trading volume was a total of 325.40K shares. On April 22, 2024, COLL opened at $34.93, traded as high as $35.31 and as low as $34.55, and closed at $34.74. Trading volume was a total of 414.70K shares. On April 23, 2024, COLL opened at $35.00, traded as high as $36.51 and as low as $34.92, and closed at $35.94. Trading volume was a total of 618.70K shares. On April 24, 2024, COLL opened at $35.83, traded as high as $36.02 and as low as $35.33, and closed at $35.48. Trading volume was a total of 302.80K shares. On April 25, 2024, COLL opened at $35.37, traded as high as $36.01 and as low as $35.05, and closed at $35.84. Trading volume was a total of 338.00K shares.
COLL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Collegium Pharmaceutical shares, starting with a $10,000 purchase of COLL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/08/2015 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$12.95 |
|
End price/share: |
$35.84 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
176.76% |
|
Average Annual Total Return: |
12.01% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$27,666.97 |
|
Years: |
8.97 |
|
|
|
Date |
Close |
04/19/2024 | $34.84 | 04/22/2024 | $34.74 | 04/23/2024 | $35.94 | 04/24/2024 | $35.48 | 04/25/2024 | $35.84 |
|
|